TY - JOUR
T1 - Hyperoxia for accidental hypothermia and increased mortality
T2 - a post-hoc analysis of a multicenter prospective observational study
AU - Yamamoto, Ryo
AU - Yoshizawa, Jo
AU - Takauji, Shuhei
AU - Hayakawa, Mineji
AU - Sasaki, Junichi
N1 - Funding Information:
This study was supported by the Japanese Association for Acute Medicine (approval no. 0005). We would like to express our gratitude to the members of the ICE-CRASH study group: Daisuke Yamada (Saiseikai Senri Hospital), Tian Tian (Kishiwada Tokushukai Hospital), Keita Minowa (Hachinohe City Hospital), Akihiko Inoue (Hyogo Emergency Medical Center), Yoshihiro Fujimoto (Japanese Red Cross Kyoto Daiichi Hospital), Shutaro Isokawa (St. Luke's International Hospital), Naoya Miura (Tokai University School of Medicine), Tomoyuki Endo (Tohoku Medical and Pharmaceutical University), Osamu Nomura (Hirosaki University), Gen Otomo (Asahikawa Red Cross Hospital), Hiroki Sato (National Hospital Organization Hokkaido Medical Center), Keisuke Bando (Sapporo City General Hospital), Tsuyoshi Suzuki (Fukushima Medical University), Takashi Toyohara (Kushiro City General Hospital), Akiko Tomita (Sunagawa City General Hospital), Motoko Iwahara (Nayoro City General Hospital), Satoru Murata (Ehime University Graduate School of Medicine), Junya Shimazaki (Osaka University Graduate School of Medicine), Takeo Matsuyoshi (Metropolitan Tama Medical Center), Kenichi Nitta (Shinshu University School of Medicine), and Yuta Sato (Aomori Prefectural Central Hospital).
Funding Information:
This study was supported by the Japanese Association for Acute Medicine (approval no. 0005). We would like to express our gratitude to the members of the ICE-CRASH study group: Daisuke Yamada (Saiseikai Senri Hospital), Tian Tian (Kishiwada Tokushukai Hospital), Keita Minowa (Hachinohe City Hospital), Akihiko Inoue (Hyogo Emergency Medical Center), Yoshihiro Fujimoto (Japanese Red Cross Kyoto Daiichi Hospital), Shutaro Isokawa (St. Luke's International Hospital), Naoya Miura (Tokai University School of Medicine), Tomoyuki Endo (Tohoku Medical and Pharmaceutical University), Osamu Nomura (Hirosaki University), Gen Otomo (Asahikawa Red Cross Hospital), Hiroki Sato (National Hospital Organization Hokkaido Medical Center), Keisuke Bando (Sapporo City General Hospital), Tsuyoshi Suzuki (Fukushima Medical University), Takashi Toyohara (Kushiro City General Hospital), Akiko Tomita (Sunagawa City General Hospital), Motoko Iwahara (Nayoro City General Hospital), Satoru Murata (Ehime University Graduate School of Medicine), Junya Shimazaki (Osaka University Graduate School of Medicine), Takeo Matsuyoshi (Metropolitan Tama Medical Center), Kenichi Nitta (Shinshu University School of Medicine), and Yuta Sato (Aomori Prefectural Central Hospital).
Publisher Copyright:
© 2023, The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - Background: Supraphysiologic oxygen administration causes unfavorable clinical outcomes in various diseases, including traumatic brain injury, post–cardiac arrest syndrome, and acute lung injury. Accidental hypothermia is a critical illness that reduces oxygen demands, and excessive oxygen is likely to emerge. This study aimed to determine whether hyperoxia would be associated with increased mortality in patients with accidental hypothermia. Methods: A post-hoc analysis of a nationwide multicenter prospective observational study (ICE-CRASH study) on patients with accidental hypothermia admitted in 2019–2022 was conducted. Adult patients without cardiac arrest whose core body temperature was < 32 °C and whose arterial partial pressure of oxygen (PaO2) was measured at the emergency department were included. Hyperoxia was defined as a PaO2 level of 300 mmHg or higher, and 28-day mortality was compared between patients with and without hyperoxia before rewarming. Inverse probability weighting (IPW) analyses with propensity scores were performed to adjust patient demographics, comorbidities, etiology and severity of hypothermia, hemodynamic status and laboratories on arrival, and institution characteristics. Subgroup analyses were conducted according to age, chronic cardiopulmonary diseases, hemodynamic instability, and severity of hypothermia. Results: Of the 338 patients who were eligible for the study, 65 had hyperoxia before rewarming. Patients with hyperoxia had a higher 28-day mortality rate than those without (25 (39.1%) vs. 51 (19.5%); odds ratio (OR) 2.65 (95% confidence interval 1.47–4.78); p < 0.001). IPW analyses with propensity scores revealed similar results (adjusted OR 1.65 (1.14–2.38); p = 0.008). Subgroup analyses showed that hyperoxia was harmful in the elderly and those with cardiopulmonary diseases and severe hypothermia below 28 °C, whereas hyperoxia exposure had no effect on mortality in patients with hemodynamic instability on hospital arrival. Conclusions: Hyperoxia with PaO2 levels of 300 mmHg or higher before initiating rewarming was associated with increased 28-day mortality in patients with accidental hypothermia. The amount of oxygen to administer to patients with accidental hypothermia should be carefully determined. Trial Registration: The ICE-CRASH study was registered at the University Hospital Medical Information Network Clinical Trial Registry on April 1, 2019 (UMIN-CTR ID, UMIN000036132).
AB - Background: Supraphysiologic oxygen administration causes unfavorable clinical outcomes in various diseases, including traumatic brain injury, post–cardiac arrest syndrome, and acute lung injury. Accidental hypothermia is a critical illness that reduces oxygen demands, and excessive oxygen is likely to emerge. This study aimed to determine whether hyperoxia would be associated with increased mortality in patients with accidental hypothermia. Methods: A post-hoc analysis of a nationwide multicenter prospective observational study (ICE-CRASH study) on patients with accidental hypothermia admitted in 2019–2022 was conducted. Adult patients without cardiac arrest whose core body temperature was < 32 °C and whose arterial partial pressure of oxygen (PaO2) was measured at the emergency department were included. Hyperoxia was defined as a PaO2 level of 300 mmHg or higher, and 28-day mortality was compared between patients with and without hyperoxia before rewarming. Inverse probability weighting (IPW) analyses with propensity scores were performed to adjust patient demographics, comorbidities, etiology and severity of hypothermia, hemodynamic status and laboratories on arrival, and institution characteristics. Subgroup analyses were conducted according to age, chronic cardiopulmonary diseases, hemodynamic instability, and severity of hypothermia. Results: Of the 338 patients who were eligible for the study, 65 had hyperoxia before rewarming. Patients with hyperoxia had a higher 28-day mortality rate than those without (25 (39.1%) vs. 51 (19.5%); odds ratio (OR) 2.65 (95% confidence interval 1.47–4.78); p < 0.001). IPW analyses with propensity scores revealed similar results (adjusted OR 1.65 (1.14–2.38); p = 0.008). Subgroup analyses showed that hyperoxia was harmful in the elderly and those with cardiopulmonary diseases and severe hypothermia below 28 °C, whereas hyperoxia exposure had no effect on mortality in patients with hemodynamic instability on hospital arrival. Conclusions: Hyperoxia with PaO2 levels of 300 mmHg or higher before initiating rewarming was associated with increased 28-day mortality in patients with accidental hypothermia. The amount of oxygen to administer to patients with accidental hypothermia should be carefully determined. Trial Registration: The ICE-CRASH study was registered at the University Hospital Medical Information Network Clinical Trial Registry on April 1, 2019 (UMIN-CTR ID, UMIN000036132).
KW - Arterial partial pressure of oxygen
KW - Hyperoxemia
KW - Oxygen toxicity
KW - Reactive oxygen species
KW - Severe hypothermia
UR - https://www.scopus.com/pages/publications/85151325378
UR - https://www.scopus.com/inward/citedby.url?scp=85151325378&partnerID=8YFLogxK
U2 - 10.1186/s13054-023-04407-8
DO - 10.1186/s13054-023-04407-8
M3 - Article
C2 - 37005646
AN - SCOPUS:85151325378
SN - 1364-8535
VL - 27
JO - Critical Care
JF - Critical Care
IS - 1
M1 - 131
ER -